ASPEN PHARMACARE H.

ASPEN PHARMACARE H.

Share · ZAE000066692 · A0ET80 (XJSE)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ASPEN PHARMACARE H.
No Price
Closing Price XJSE 28.04.2026: 13.965,00 ZAC
28.04.2026 20:00
Current Prices from ASPEN PHARMACARE H.
ExchangeTickerCurrencyLast TradePriceDaily Change
OTC: UTC
UTC
APNHF
USD
28.04.2026 20:00
8,69 USD
0,00 USD
XJSE: JSE
JSE
APN.JO
ZAc
28.04.2026 15:00
13.965,00 ZAC
37,00 ZAC
+0,27 %
XHAN: Hannover
Hannover
APHPLC92.HANB
EUR
28.04.2026 06:03
7,10 EUR
-
XDQU: Quotrix
Quotrix
APHPLC92.DUSD
EUR
28.04.2026 05:27
7,20 EUR
-
XDUS: Düsseldorf
Düsseldorf
APHPLC92.DUSB
EUR
27.04.2026 17:30
7,05 EUR
-
Share Float & Liquidity
Free Float 82,56 %
Shares Float 366,58 M
Shares Outstanding 444,02 M
Invested Funds

The following funds have invested in ASPEN PHARMACARE H.:

Fund
iShares MSCI South Africa UCITS ETF USD (Acc)
Vol. in million
2.034,40
Percentage (%)
2,06 %
Fund
iShares MSCI EM SRI UCITS ETF USD (Acc)
Vol. in million
9.592,66
Percentage (%)
0,38 %
Fund
iShares MSCI EM SRI UCITS ETF USD (Dist)
Vol. in million
847,93
Percentage (%)
0,38 %
Fund
iShares MSCI EM ex-China UCITS ETF USD (Acc)
Vol. in million
17,02
Percentage (%)
0,10 %
Fund
iShares MSCI EM ESG Enhanced UCITS ETF USD (Acc)
Vol. in million
1.044,27
Percentage (%)
0,09 %
Company Profile for ASPEN PHARMACARE H. Share
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.

Company Data

Name ASPEN PHARMACARE H.
Company Aspen Pharmacare Holdings Limited
Website https://www.aspenpharma.com
Primary Exchange XJSE JSE
WKN A0ET80
ISIN ZAE000066692
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Stephen Bradley Saad BCom,
Market Capitalization 4 Mrd.
Country South Africa
Currency EUR
Employees 8,9 T
Address Aspen Place, Durban
IPO Date 2000-01-04
Dividends from 'ASPEN PHARMACARE H.'
Ex-Date Dividend per Share
01.10.2025 211,00 ZAC
18.09.2024 359,00 ZAC
20.09.2023 342,00 ZAC
21.09.2022 326,00 ZAC
21.09.2022 0,18 USD
21.09.2021 262,00 ZAC
21.09.2021 0,18 USD
03.10.2018 315,00 ZAC
03.10.2018 0,22 USD
04.10.2017 287,00 ZAC

Stock Splits

Date Split
19.04.2016 1:3
09.10.2008 1017:1000
06.10.2008 1017:1000

Ticker Symbols

Name Symbol
Over The Counter APNHF
Düsseldorf APHPLC92.DUSB
Frankfurt LDZA.F
Hannover APHPLC92.HANB
JSE APN.JO
Quotrix APHPLC92.DUSD
More Shares
Investors who hold ASPEN PHARMACARE H. also have the following shares in their portfolio:
ALB.1/AGG.H. 25/30 REGS
ALB.1/AGG.H. 25/30 REGS Bond
ITV 15/22
ITV 15/22 Bond